Medtronic (NYSE:MDT) is providing additional facts in response to a New York Times report detailing an acquisition by Covidien that allegedly changed the course of a government contract designed to increase ventilator supply, now a major problem amid the coronavirus pandemic. Medtronic bought Covidien for $50 billion in 2015 — years after the events described in the […]
FDA gives Covidien recall highest-risk label
The FDA this week put its highest-risk label on medical device maker Covidien’s (NYSE:COV) recent ventilator battery recall, warning that the device may cause patients harm.
More deals ahead for Covidien? | Wall Street Beat
Covidien grabs Newport Medical Instruments for $108 million
Covidien (NYSE:COV) continued to blaze the acquisitions trail, announcing a definitive agreement to acquire Newport Medical Instruments for $108 million.
Costa Mesa, Calif.-based Newport Medical is a ventilator systems maker with products on the market in the U.S. and more than 115 countries worldwide, according to a press release.
